Bill, 76, joined a clinical trial at SCRI to treat stage IV prostate cancer. His goal: dance at his daughter’s wedding. ✅ Now celebrating a grandchild & still practicing law—while seeing a 15% reduction in disease. Hope lives here. 🔗 www.scri.com/patients/?co... #SCRI #ClinicalTrials #ProstateCancer

🎧 SCRI’s Dr. Garmezy & Dr. Bupathi share expert insights on treating variant histologies in GU cancers at #WorldGU2025 on Oncology Decoded. 🔗 www.cancernetwork.com/view/episode... #SCRI #CancerResearch #GUOncology #OncologyDecoded

Mary is proof that hope and research go hand in hand. She’s in a clinical trial for IV #ovariancancer at #SCRI at Mary Crowley—and her disease has remained stable since March. She’s walked the Camino de Santiago, joined the Lourdes Pilgrimage, & got a tattoo to celebrate it all. #PatientStories

Dr. Hans Lee & Dr. Kris Patel from SCRI Oncology share how new therapies like CAR T-cell treatment are changing lives. 📺 Watch the News Channel 5 segment: www.youtube.com/watch?v=hg4_... #BloodCancerAwareness #LymphomaAwareness #CancerCare #SCRI

Dr. Jason Henry featured on @DenverChannel discussing early data from a promising #pancreaticcancer vaccine. “This is one of the most exciting times in pancreatic cancer research in the last 100 years.” #SCRI #CancerResearch #ClinicalTrials www.denver7.com/lifestyle/he...

“Prostate cancer is often treatable—if caught early.” Dr. Benjamin Garmezy shares why early screening matters and how new therapies are offering hope. 🎥 Watch the clip: youtu.be/tMnvf31VWN8 #ProstateCancerAwareness #MensHealth #CancerResearch #SCRIOncology

Joseph, a physician & mountain biking coach, was diagnosed with AML in 2023. A clinical trial at SCRI helped him return to biking, coaching, and living fully. 💬 Read his story: www.scri.com/patients/?co... #AML #SCRI #ClinicalTrials #Hope

New studies in ASH’s Blood Advances show significant quality-of-life gains for patients with #SickleCell & #BetaThalassemia. From hospital beds to classrooms & workplaces, read how CRISPR is giving new opportunities to pts. #GeneTherapy #ExaCel #CRISPR #Hematology

Dr. Hans Lee joins OncLive On Air to discuss FDA approval of linvoseltamab for relapsed/refractory multiple myeloma. A new option for patients with limited therapies. 🔗 www.onclive.com/view/fda-app... #MultipleMyeloma #SCRI #FDAApproval

Kim’s story is a powerful reminder of what clinical trials can offer. After receiving treatment through SCRI and Alliance Cancer Specialists, today, she’s an advocate, fundraiser, and survivor. www.scri.com/patients/?co... #SCRI #OvarianCancerAwareness #ClinicalTrialsMatter #PatientStories

Early data from a personalized mRNA vaccine shows promise in delaying recurrence in pancreatic cancer. Dr. Jason Henry shares why this is generating hope. 🔗 www.onclive.com/view/persona... #PancreaticCancer #CancerVaccine #SCRI

FDA accepts NDA for vepdegestrant in ER+/HER2– metastatic breast cancer. Dr. Erika Hamilton highlights the VERITAC-2 trial’s impact on this promising therapy. 🔗 www.onclive.com/view/fda-acc... #BreastCancer #VERITAC2 #SCRI #FDAApproval

In Oncology Decoded, SCRI's Drs. Bupathi and Garmezy, discuss evolving strategies for treating urothelial carcinoma beyond first-line therapy, particularly in light of recent FDA approvals. Listen to the episode: www.cancernetwork.com/view/episode...

Lisa’s story is one of resilience and research. Diagnosed with triple-negative breast cancer while pregnant, she beat the odds through a clinical trial at SCRI. Nearly 20 years later, she’s cancer-free — and her journey continues to inspire. www.scri.com/patients/?co... #PatientStories

Welcome Dr. Sarah Premji to Sarah Cannon Research Institute! As Assistant Director of Breast Cancer Research, she brings deep expertise and passion for patient-centered care. 📄 Full story: www.scri.com/news/sarah-c... #SCRI #CancerResearch #Leadership #BreastCancer

🧬 “AQUILA is a big trial… and there’s a trend toward improved OS.” – SCRI expert, Dr. Burke on daratumumab for high-risk smoldering #MultipleMyeloma in Targeted Therapies in Oncology. ODAC votes 6–2 in favor. FDA decision pending. 📖 Read: www.targetedonc.com/view/dr-burk...

85% of cancer patients stay local for care. Now, they can access clinical trials too—thanks to partnerships with SCRI. 🎥 Watch how we’re bringing hope and innovation closer to home: youtu.be/u_Ay6R9Mj_A #CancerCare #ClinicalTrials #SCRI #OncologyResearch #HopeCloseToHome

JP was diagnosed with stage IV lung cancer. He joined a clinical trial through SCRII at OHC—and responded to immunotherapy. Now in remission, he celebrates each year with a cake and a message of hope. 🎂 #SCRI #CancerSurvivor #Immunotherapy #ClinicalResearch www.scri.com/patients/?co...

How do we bring #PrecisionMedicine to every cancer patient? Jason Hammonds (#TheUSOncologyNetwork) spotlights insights from Dr. Eric Lander and Andrew McKenzie on simplifying workflows, integrating trials, and empowering providers in #communityoncology. www.targetedonc.com/view/expandi...

New from #CancerNetwork: Dr. Erika Hamilton of SCRI Oncology Partners shares insights on ADCs, CDK4/6 inhibitors & early breast cancer care from #IBC25. 🎧 Listen: www.cancernetwork.com/view/highlig... #BreastCancer #Oncology #SCRI

💡 Why consider a clinical trial during your cancer journey? ✨ Access cutting-edge treatments ✨ Stay close to home ✨ Help shape the future of cancer care 🎥 Watch our latest video to learn more: www.scri.com/patients/ #CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome

“Can we use the immune system to fight cancer?” Dr. David Spigel of SCRI Oncology Partners answers on #NewsChannel5. Immunotherapy is changing lives—and Nashville is leading the charge. 🎥 Watch the segment: youtu.be/n45JFZZIy0Q #CancerResearch #Immunotherapy #ClinicalTrials #Nashville

Thank you, #ASCO25! We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration. Here’s to advancing therapies for patients —together. Until next year! #SCRI #CancerResearch #OncologyLeadership #ThankYouASCO

Dr. Meredith McKean delivers her oral presentation on Novel Targets in #Melanoma Treatment at #ASCO2025

Dr. Naqash serves as chair in the Oral Abstract Session: Lung Cancer-Non-Small Cell Local-Regional/ Small Cell/ Other Thoracic Cancers session. #ASCO25

New data from the AIM-HIGH trial presented by Dr. David Spigel at #ASCO25 shows a 78% relative reduction in recurrence or death with adjuvant chemo for high-risk early-stage #NSCLC patients, identified via a 14-gene molecular assay. Watch interview here: ascopost.com/videos/2025-...

🚨 LIVE from #ASCO25 🚨 Dr. Erika Hamilton presents first-in-human data on Emi-Le (B7-H4 ADC) in solid tumors. 🔹 ORR: 31% in B7-H4 high 🔹 ORR: 44% w/ ≤4 prior lines 🔹 ACC-I: 55.6% ORR Promising activity + tolerability in mBC, OC, EC & ACC-I. #SCRI #ADC #Oncology #ASCO2025

We look forward to seeing more of you on day four of the #ASCO25 Annual Meeting. Stop by both #27022 to meet experts from across the network, from 9:45am-2:00pm. #CancerResearch uberflip.scri.com/i/1535506-me...

Dr. Johnson tackled how community oncology can deliver cutting-edge lung cancer therapies: 🔹 Not all bispecifics need inpatient care 🔹 Tarlatamab = outpatient-friendly 🔹 Innovative care models = better access #LungCancer #Immunotherapy #SCRI #ASCO25

🔬 At #ASCO25, Dr. Naqash explored the promise & challenges of bispecific T-cell engagers (BiTEs) in lung cancer & beyond: ✅ Tarlatamab earns FDA nod for SCLC ⚠️ CRS & ICANS toxicity management is key 🎯 DLL3 & other targets may expand BiTE reach #Immunotherapy #LungCancer #SCRI

At #ASCO25, Dr. @ErikaHamilton9 presented Phase 3 VERITAC-2 results: 🧬 Vedegestrant (first PROTAC ER degrader) showed: ✅ Significant PFS benefit vs fulvestrant (ESR1m ER+/HER2- ABC) ✅ Favorable safety (<5% AEs led to dose changes) ⏳ OS data maturing A promising new option!

Dr. Frangoul and patient, Jimi, take the stage in a powerful #AACR/#ASCO joint session, showcasing both side of what it means to explore real-world gene therapy: successes, challenges & equitable access. #ASCO25

Dr. Skip Burris, President of #SCRI, takes the stage to honor this year’s Top Donors—recognizing the individuals and organizations driving progress in cancer research and care. Grateful for those fueling the future of oncology. #ASCO25 #CancerResearch #ASCOOpeningSession

🚨 LIVE from #ASCO25: Dr. Dax Kurbegov shares promising results on a reflex blood-based #MCED test for people with obesity. 🧬 Fills a critical screening gap 📈 Strong PPV & early-stage sensitivity 🔍 Targets cancers w/ no current screening ✅ Warrants prospective validation

At #ASCO25 Dr. Fontana presents: KRAS G12C: From First to Next Gen • Early trials: safe KRAS G12C + anti-EGFR ± chemo • No unexpected toxicities • Promising, but not practice-changing • FDA-approved:  – Sotorasib + panitumumab  – Adagrasib + cetuximab #GIcancer #KRASG12C

Live from #ASCO25! 🔬 Dr. Patt shared how ASCO is leveraging AI with Google Cloud to enhance decision support & pt care.🩸 Dr. Andorsky unveiled promising interim results on asciminib for CML-CP after one TKI. #OncologyAI #CancerCare #CML

At SCRI, we’re dedicated to advancing cancer research for patients. Our team accelerates progress through innovative clinical trials—because today’s research leads to tomorrow’s therapies. Meet us at the #ASCO25 and discover what’s next in oncology. www.scri.com/asco/

We are pleased to announce that SCRI leaders will highlight our latest research insights through more than 155 accepted abstracts and presentations at the 2025 ASCO Annual Meeting. For more information, read the press release: www.scri.com/news/sarah-c... #ASCO25 #CancerResearch #Oncology #SCRI

We’re thrilled to announce a strategic alliance with @abbvie.bsky.social to accelerate innovative cancer therapies and enhance clinical trial delivery. Learn more: www.scri.com/news/sarah-c... #Oncology #CancerResearch #ClinicalTrials #PharmaNews #HealthcareInnovation #SCRI #AbbVie

May is Melanoma Awareness Month! SCRI's Dr. Meredith McKean shares expert insights on uveal melanoma, a rare eye cancer. Hear about her patient Mike’s journey: www.scri.com/patients/?co... #UvealMelanoma #MelanomaAwareness #PatientStories #SCRI #CancerResearch

We’re thrilled to welcome Dr. Hans Lee as Director of Myeloma Research at SCRI! 🎉 A global leader in myeloma care, Dr. Lee joins us from MD Anderson and will serve patients in Nashville starting June 1. #Myeloma #CancerResearch #Oncology #SCRI 🔗 www.scri.com/news/sarah-c...

SCRI and IQVIA are collaborating to accelerate oncology trials globally. Together, we can eliminate operational hurdles, accelerate data delivery, and expedite the availability of cutting-edge therapies. Learn more: www.scri.com/news/iqvia-a... #ClinicalTrials #ASCO25

This #OncologyNursingMonth, we honor our exceptional nurses across SCRI. Your commitment to patient care and your expertise in oncology are truly inspiring. Please take a moment to watch this video where our colleagues share their heartfelt thanks. 💙 #ThankYouNurses #HealthcareHeroes

SCRI expert, Dr. Stephen Strickland presented interim results for SENTI-202 at #AACR2025. This CAR NK cell therapy shows potential in treating relapsed AML, with several patients achieving complete remission. Read more www.usnews.com/news/health-... #CancerResearch #CAR_NK_Therapy #AML #USNews

SCRI expert, Dr. Susanna Ulahannan, presented promising data in the STELLA Phase 1/2a trial for ART0380 at #AACR25. Conducted by our CRO, SCRI Development Innovations, it has shown significant clinical responses in ATM-negative & ATM-low solid tumors. bit.ly/3RFtKCI #OUStephensonCancerCenter

April is #TesticularCancerAwarenessMonth! Dr. Garmezy from SCRI Oncology stresses the importance of self-exams and shares breakthroughs in treatment. Let's spread awareness! 🔬 Read more: www.newschannel5.com/news/let-me-...

Ivy's journey from Mississippi to Nashville for her battle with stage IV melanoma is inspiring! Thanks to a clinical trial at SCRI Oncology Partners and Dr. McKean's care, she's now cancer-free. Her story is one of hope, resilience, and the power of medical innovation. www.scri.com/patients/?co...

🎧 Dive into the latest Oncology Decoded podcast! Drs. Manoj Bupathi & Benjamin Garmezy discuss optimizing therapy for mHSPC at the 2025 ASCO Symposium. Explore treatment strategies, imaging, and more with top experts! Listen now: #ProstateCancer #SCRI www.cancernetwork.com/view/episode...

SCRI is transforming cancer care through groundbreaking trials at 250 locations in 24 states. Join us in advancing therapies and offering hope. Watch how we collaborate to make a difference. #CancerResearch #ClinicalTrials #NewHope #SCRI scri.com

🚀 Big news from SCRI! Dr. David Spigel presented results: Durvalumab shows a 27% reduction in death risk & a 22.5-month median survival boost in our global trial! Watch the video below to learn more. #TargetedOncology #ClinicalTrials #SCRI www.targetedonc.com/view/adriati...